Bortezomib CAS: 179324-69-7
| Product Parameters | |
|---|---|
| Catalog No. | BA806B |
| CAS.RN | 179324-69-7 |
| Molecular Formula | C19H25BN4O4 |
| Molecular Weight | 384.24 g/mol |
| Purity | NLT 98% |
Product Overview
Bortezomib is a reversible proteasome inhibitor widely used in the development of anti-tumor drugs and is an important targeted therapy for multiple myeloma and mantle cell lymphoma. As an active pharmaceutical ingredient (API), its core positioning is as a pharmaceutical intermediate and a key starting material for innovative drugs, suitable for all stages of process development, including R&D, pilot-scale, and large-scale production. This product possesses high purity, stability, and good bioactivity, meeting the high standards of pharmaceutical companies for API quality and supply, and facilitating the smooth transition from laboratory to commercial production for clients.
Applications
- Anti-tumor drug development
- Synthesis of drugs for the treatment of multiple myeloma
- Preparation of targeted therapies for mantle cell lymphoma
- Custom synthesis of pharmaceutical intermediates
- Development and optimization of innovative drug processes
Quality & Supply Capability
English Name: Bortezomib Properties: White crystalline powder, readily soluble in organic solvents, with a stable chemical structure, exhibiting highly selective inhibition of proteasomes, meeting pharmaceutical-grade API standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We can flexibly adjust supply solutions according to customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we provide comprehensive technical support from laboratory R&D to scale-up production, helping customers advance process development, route optimization, and project transformation, ensuring product quality and delivery efficiency, and meeting the needs of research and production at different stages.
Why Choose Bioncan
Focused on pharmaceutical raw materials, possessing extensive product experience and technological expertise. Full-scale supply capabilities, covering all stages from laboratory to commercial production. Provides complete quality control documentation, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, enabling process adjustments and product optimization based on specific customer requirements. Provides comprehensive scale-up technical support, helping customers achieve a seamless transition from R&D to mass production.
Intermediates of Bortezomib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA806B | Bortezomib API | 179324-69-7 |
| BK4Q1E | (S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID | 114457-94-2 |
| BK8D05 | (R)-BoroLeu-(+)-Pinanediol-HCl | 779357-85-6 |
| BK97BA | (R)-BoroLeu-(+)-Pinanediol trifluoroacetate | 179324-87-9 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 179324-69-7, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.